Already approved for Dravet syndrome, fenfluramine (Fintepla) for seizure control in LGS was supported by data from a global, randomized, placebo-controlled phase 3 clinical trial. FDA Approvals
Already approved for Dravet syndrome, fenfluramine (Fintepla) for seizure control in LGS was supported by data from a global, randomized, placebo-controlled phase 3 clinical trial. FDA Approvals